Konferenser och symposier The KI-J&J Innovative Medicine Partnership Annual Meeting

Welcome to the annual meeting and the celebration of 10 years of collaboration between KI and J&J Innovative Medicine, showcasing and highlighting the value of the ongoing joint research program between both organizations.

Collaboration between KI and J&J Innovative Medicine: Multi-faceted Research Collaboration for Advanced Real-World Evidence, Biomarker, and Translational Research. 

J&J Innovative Medicine and KI are working together with the goal of improving health outcomes for patients by accelerating and enhancing translational research and real-world evidence. The partnership is built on dynamic collaboration, openness and transparency for the mutual benefit of both organizations, advancement of science and patient outcomes.

The research collaboration in advanced real-world evidence (RWE), biomarker, and translational research was initiated by J&J Innovative Medicine (formerly Janssen Pharmaceutica NV) and Karolinska Institutet in 2015, with an initial focus on applied data science and RWE research together with pharmacoepidemiologic and RWE methods development. In 2019, this research collaboration was expanded in scope to encompass translational research, and research projects have also been initiated across additional disease areas and indications.  

Learn more about the KI- J&J Innovative Medicine partnership here

Target Group 

KI researchers, KI PhD students, KI employees, Karolinska Universitetssjukhuset (K) employees and J&J Innovative Medicine employees

Agenda 

The event will run over two consecutive half-days (afternoons) in a hybrid format and will showcase the value of the joint research program between J&J Innovative Medicine and Karolinska Institutet.

Please see the preliminary Agenda below and here

Day 1, May 14^th

Hybrid with Speakers online and IRL in Ragnar Granit (updated location), Biomedicum, Campus Solna, KI

13:30- 13:40 - Welcome and Introduction by Carl-Johan Sundberg the Dean of Karolinska Institutet North Campus

13:40- 14:15 - Unlocking the Potential of Collaboration: A Decade of Partnership between Karolinska Institutet and J&J Innovative Medicine, Shane Kavanagh (J&J), Richard Cowburn (KI) and Mario Klesse (J&J)

14:15- 15:15 - Together Towards Clinical Impact: Stories from the Partnership:

• Alzheimer’s Disease Program by Miia Kivipelto (KI)
• Mood and Depression Disorders by Johan Reutfors (KI) and Onus Tankaya (J&J)

15:15-15:45 - Coffee & Networking + Poster Gallery 

15:45- 16:05 - J&J Women in STEM Scholarship award 2023 to KI researcher, Laura Baranello - The mechanism of action of topoisomerases, Moderated by Ingrid Lekander (J&J)

16:05- 16:40 - Clinical Challenges and Emerging Therapies in Geographic Atrophy by Daniel Muth (KI) 

16:40- 17:30 - Panel Discussion "Navigating AI in Healthcare: Overcoming Challenges and Implementing Solutions" Johan Hartman (KI), Johanna Furuhjelm (KI) and Tommaso Mansi (J&J),       Moderated by Paul Ashley (J&J)

17:30 - Refreshments and Mingle

Day 2, May 15^th

Hybrid with Speakers online and IRL in Ragnar Granit room, Biomedicum, Campus Solna, KI

13:30- 15:30 - Session 1 - Immunology, Rheumatology, Dermatology Moderated by Per-Johan Jakobsson (KI):

• SwedAD – the national registry for systemic pharmacotherapy in atopic dermatitis, Emma Johansson (KI)
• Tissue resident T cells maintain localised disease memories in psoriasis, Liv Eidsmo (KI)
• Idiopathic Inflammatory Myopathies project update by Marie Holmqvist (KI) and Elizabeth  Hsia (J&J)
• Extended Discussion in Immunology with focus on dermatology:

  • Intro: Leading a multi-pathway approach to transform treatment in atopic dermatitis  – J&J research and development focus ​

  • Discussion: with Emma Johansson (KI), Liv Eidsmo (KI), Mawuli Nyaku (J&J), Nan Li (J&J) and Steven Fakharzadeh (J&J)

15:30-16:00 - Coffee and Networking

16:00-17:30 Session 2: Ophthalmology and Neuroscience Moderated by Shane Kavanagh (J&J)

• Inherited Retinal Disease project update, Muwada Bashir (KI)
• Alzheimer’s Disease project update, Miia Kivipelto and Anna Matton (KI)
• Mood and Depression Disorders project update, Johan Reutfors (KI)

Organizers 

Karolinska Institutet in collaboration with J&J Innovative Medicine

Registration

Please use your official email address (KI, K or J&J) when signing up to this event. Information on how to join the event will be provided upon registration or upon registration closing date. 

Sign-up here, registration open until May 14^th

Contact 

Please contact alliancemanagers@ki.se if you have any questions regarding this event.